Artwork for Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
Journal of Clinical Oncology (JCO) Podcast

Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
00:00:00 / 00:09:21